Canada: Parkinson's guidelines set standard for care

July 24, 2012 in Parkinson's & Movement disorders

(Medical Xpress) -- It’s been five years in the making but health-care workers across the country now have guidelines on how to diagnose and treat patients with Parkinson’s disease.

Parkinson Society Canada, as well as Canada’s top movement-disorder specialists and neurologists, released the in mid-June. The Faculty of Medicine & Dentistry at the University of Alberta is home to three of the authors: Wayne Martin, Oksana Suchowersky and Marguerite Wieler.

The 84 recommendations will provide health-care professionals with practical, clinical advice for diagnosis and treatment of Parkinson’s, based on published evidence and expert consensus.

“We knew that guidelines existed in other countries but we felt that it was important to have Canada-specific guidelines,” said Martin, a professor in the Department of Medicine. “Neurologists are writing the guidelines but they’re useful for family physicians, physiotherapists, nurses and anyone who deals with patients who have Parkinson’s.”

“We are delighted to launch the Canadian Guidelines on Parkinson’s Disease, which we believe will lead to better, more consistent and more accessible care for Canadians with Parkinson’s,” says Joyce Gordon, president and CEO of Parkinson Society Canada. “The guidelines will result in earlier diagnosis, better treatment, increased awareness and better health-care policies for Canadians with Parkinson’s.”

More than 100,000 Canadians have Parkinson’s disease and a lot of those people don’t live in the major centres that are home to specialized movement-disorder clinics. This means patients in rural areas are relying on their local family physician and other allied health-care professionals.

“There aren’t enough speciality clinics to meet the needs of everyone who has Parkinson’s,” said Wieler, research associate and program manager with the Movement Disorders Program at the University of Alberta/Glenrose Rehabilitation Hospital. “These guidelines allow non-specialists to have a sense of what is the standard of care.”

The guidelines will be distributed to family physicians, pharmacists, nurses and allied health professionals, including occupational therapists, physiotherapists and speech-language pathologists.

“There’s increasing recognition among the group that is dealing with Parkinson’s that they need a lot more than just doctors,” said Martin.

Parkinson’s disease affects many systems, including movement, mood and cognition. The typical age of onset is mid-50s in most patients, but about 10 per cent of show symptoms before the age of 40.

The guidelines will be published in the Canadian Journal of Neurological Sciences and can also be viewed at www.parkinsonclini… uidelines.ca

Provided by University of Alberta search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Diabetes drug tested in Parkinson's disease patients

Parkinson's disease (PD) is a degenerative neurological disorder marked by a progressive loss of motor control. Despite intensive research, there are currently no approved therapies that have been demonstrated to alter the ...

Parkinson's & Movement disorders created May 20, 2013 | popularity not rated yet | comments 0

Faulty energy production in brain cells leads to disorders ranging from Parkinson's to intellectual disability

Neuroscientist Patrik Verstreken of VIB (Flanders Institute for Biotechnology) and KU Leuven has shown for the first time that dysfunctional mitochondria in brain cells can lead to learning disabilities. The link between ...

Parkinson's & Movement disorders created May 17, 2013 | popularity 4 / 5 (2) | comments 0

Unleashing the watchdog protein

McGill University researchers have unlocked a new door to developing drugs to slow the progression of Parkinson's disease. Collaborating teams led by Dr. Edward A. Fon at the Montreal Neurological Institute and Hospital -The ...

Parkinson's & Movement disorders created May 09, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Could eating peppers prevent Parkinson's? Dietary nicotine may hold protective key

New research reveals that Solanaceae—a flowering plant family with some species producing foods that are edible sources of nicotine—may provide a protective effect against Parkinson's disease. The study appearing today ...

Parkinson's & Movement disorders created May 09, 2013 | popularity not rated yet | comments 0

Study reveals probable role of Parkinson's protein in healthy brain

(Medical Xpress)—Researchers at the Stanford University School of Medicine have exposed the possible function, in the healthy brain, of a mysterious molecule that has been strongly implicated in Parkinson's ...

Parkinson's & Movement disorders created May 01, 2013 | popularity 5 / 5 (3) | comments 0 | with audio podcast


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.